The Latest Cardiac and Vascular News
Prospective, international, multicenter, observational study to assess the real-world safety and efficacy of the WRAPSODY Cell-Impermeable Endoprosthesis SOUTH JORDAN, Utah, July 05, 2022 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today the successful enrollment of the first patient […]
SOUTH JORDAN, Utah, April 21, 2022 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, is proud to announce that Brian G. Lloyd, Merit’s Chief Legal Officer and Corporate Secretary, is a recipient of Utah Business Magazine’s Corporate Counsel Award. The award recognizes exceptional […]
Q4 2021 reported revenue of $278.5 million, up 7.9% on a reported basis and up 8.4% on a constant currency revenue, organic* basis, compared to Q4 2020 Q4 2021 GAAP EPS increased 32% year-over-year to $0.36, compared to $0.27 in Q4 2020 Q4 2021 non-GAAP EPS* increased 31% year-over-year to […]
Q3 2021 reported revenue of $267.0 million, up 9.4% compared to Q3 2020 Q3 2021 constant currency revenue, organic* up 8.8% compared to Q3 2020 Q3 2021 GAAP EPS of $0.21, compared to GAAP loss per share of ($0.05) in Q3 2020 Q3 2021 non-GAAP EPS* of $0.52, compared to […]
Prospective, observational study published in CardioVascular and Interventional Radiology1 reports 100% target lesion primary patency (“TLPP”) rate without reintervention through 30 days, with a 12-month TLPP rate of 84.6% and a 12-month access circuit primary patency (“ACPP”) rate of 65.9%. Authors conclude the results suggest WRAPSODY Endoprosthesis is a safe and […]
Advanced design makes sample collection simple, efficient, and safe SOUTH JORDAN, Utah, Aug. 16, 2021 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy, […]
April 29, 2021 16:05 ET | Source: Merit Medical Systems, Inc. Q1 2021 reported revenue of $248.9 million, up 2.2% compared to Q1 2020 Q1 2021 constant currency revenue, organic* up 0.6% compared to Q1 2020 Q1 2021 GAAP EPS of $0.19, compared to GAAP loss per share of ($0.06) in Q1 […]
U.S. pivotal study to determine safety and effectiveness of the WRAPSODY Endovascular Stent Graft System in the treatment of dialysis outflow circuit stenosis or occlusion SOUTH JORDAN, Utah, March 11, 2021 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices […]
Q4 2020 reported revenue of $258.0 million, approximately equal to Q4 2019 revenue Q4 2020 core revenue on a constant currency basis* down (1.0)% compared to Q4 2019 Q4 2020 GAAP EPS of $0.27, compared to GAAP loss per share of ($0.08) in Q4 2019 Q4 2020 non-GAAP EPS* of […]
SOUTH JORDAN, Utah, Nov. 10, 2020 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, will hold an investor call today to introduce its […]
